Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 2'-((5-(4-methyl-1-piperazinyl)-2-pyridinyl)amino)-7',8'-dihydro-6'h-spiro(cyclohexane-1,9'-pyrazino(1',2':1,5)pyrrolo(2,3-d)pyrimidin)-6'-one
2. Cosela
3. Spiro(cyclohexane-1,9'(6'h)-pyrazino(1',2':1,5)pyrrolo(2,3-d)pyrimidin)-6'-one, 7',8'-dihydro-2'-((5-(4-methyl-1-piperazinyl)-2-pyridinyl)amino)-
4. Trilaciclib
1. 1977495-97-8
2. Trilaciclib Dihydrochloride
3. Trilaciclib 2hcl
4. G1t28 Hydrochloride
5. G1t28 Dihydrochloride
6. Trilaciclib (hydrochloride)
7. 4bx07w725t
8. Cosela
9. 2'-((5-(4-methylpiperazin-1-yl)pyridin-2-yl)amino)-7',8'-dihydro-6'hspiro(cyclohexane-1,9'-pyrazino(1',2':1,5)pyrrolo(2,3-d)pyrimidin)-6'-one Dihydrochloride
10. 4-[[5-(4-methylpiperazin-1-yl)pyridin-2-yl]amino]spiro[1,3,5,11-tetrazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraene-13,1'-cyclohexane]-10-one;dihydrochloride
11. Spiro(cyclohexane-1,9'(6'h)-pyrazino(1',2':1,5)pyrrolo(2,3-d)pyrimidin)-6'-one, 7',8'-dihydro-2'-((5-(4-methyl-1-piperazinyl)-2-pyridinyl)amino)-, Hydrochloride (1:2)
12. Unii-4bx07w725t
13. Chembl4650272
14. Trilaciclib Hydrochloride(g1t28)
15. Bcp25727
16. Ced49597
17. Ex-a4296
18. At27978
19. Cs-7942
20. Hy-101467a
21. Sb19784
22. G1t28 Dihydrochloride;trilaciclib 2hcl
23. G1t28 Hydrochlorideg1t28 Hydrochloride
24. Ac-36548
25. Trilaciclib Dihydrochloride [who-dd]
26. Trilaciclib Dihydrochloride [orange Book]
27. A901868
28. 12'-{[5-(4-methylpiperazin-1-yl)pyridin-2-yl]amino}-2',5',11',13'-tetraazaspiro[cyclohexane-1,3'-tricyclo[7.4.0.0(2),]tridecane]-1'(9'),7',10',12'-tetraen-6'-one Dihydrochloride
29. 1374635-07-0
Molecular Weight | 519.5 g/mol |
---|---|
Molecular Formula | C24H32Cl2N8O |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 3 |
Exact Mass | g/mol |
Monoisotopic Mass | g/mol |
Topological Polar Surface Area | 91.2 |
Heavy Atom Count | 35 |
Formal Charge | 0 |
Complexity | 707 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
22
PharmaCompass offers a list of Trilaciclib Dihydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Trilaciclib Dihydrochloride manufacturer or Trilaciclib Dihydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Trilaciclib Dihydrochloride manufacturer or Trilaciclib Dihydrochloride supplier.
PharmaCompass also assists you with knowing the Trilaciclib Dihydrochloride API Price utilized in the formulation of products. Trilaciclib Dihydrochloride API Price is not always fixed or binding as the Trilaciclib Dihydrochloride Price is obtained through a variety of data sources. The Trilaciclib Dihydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Trilaciclib Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Trilaciclib Hydrochloride, including repackagers and relabelers. The FDA regulates Trilaciclib Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Trilaciclib Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Trilaciclib Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Trilaciclib Hydrochloride supplier is an individual or a company that provides Trilaciclib Hydrochloride active pharmaceutical ingredient (API) or Trilaciclib Hydrochloride finished formulations upon request. The Trilaciclib Hydrochloride suppliers may include Trilaciclib Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Trilaciclib Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Trilaciclib Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Trilaciclib Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Trilaciclib Hydrochloride DMFs exist exist since differing nations have different regulations, such as Trilaciclib Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Trilaciclib Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Trilaciclib Hydrochloride USDMF includes data on Trilaciclib Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Trilaciclib Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Trilaciclib Hydrochloride suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Trilaciclib Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Trilaciclib Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Trilaciclib Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Trilaciclib Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Trilaciclib Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Trilaciclib Hydrochloride suppliers with NDC on PharmaCompass.
Trilaciclib Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Trilaciclib Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Trilaciclib Hydrochloride GMP manufacturer or Trilaciclib Hydrochloride GMP API supplier for your needs.
A Trilaciclib Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Trilaciclib Hydrochloride's compliance with Trilaciclib Hydrochloride specifications and serves as a tool for batch-level quality control.
Trilaciclib Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Trilaciclib Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Trilaciclib Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Trilaciclib Hydrochloride EP), Trilaciclib Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Trilaciclib Hydrochloride USP).